Specific reversal of tumor-suppressor gene promoter hypermethylation with bovine oocyte extract

Oncology Reports

Volumn 30, Issue 1, 2013, Pages 179-184

  Wang, Zhenfei ^a   Gao, Haixia ^a   Wang, Huimin ^a   Ren, Xiaolu ^a   Bao, Luri ^a   Sa, Rula ^a   Wang, Jie ^a   Bai, Haidong ^a   Yu, Haiquan ^a  

^a INNER MONGOLIA UNIVERSITY   (China)

Author keywords

Bovine oocyte extract; Demethylation; Promoter; Tumor suppressor gene

Indexed keywords

BOVINE OOCYTE EXTRACT; CELL EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CDH1 GENE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN H460; CONTROLLED STUDY; COW; DNA METHYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NONHUMAN; OOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RASSF1A GENE; RUNX3 GENE; TUMOR SUPPRESSOR GENE; UPREGULATION; WIF1 GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BASE SEQUENCE; CADHERINS; CATTLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA METHYLATION; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; OOCYTES; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; SEQUENCE ANALYSIS, DNA; TISSUE EXTRACTS; TUMOR SUPPRESSOR PROTEINS;

EID: 84878177907     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2449     Document Type: Article

References (18)

1. Huang YW, Kuo CT, Stoner K, Huang TH and Wang LS: An overview of epigenetics and chemoprevention. FEBS Lett 585: 2129-2136, 2011.
2. Hamm CA, Xie H, Costa FF, Vanin EF, Seftor EA, Sredni ST, Bischof J, Wang D, Bonaldo MF, Hendrix MJ and Soares MB: Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2'-deoxycytidine results in increased tumorigenicity. PLoS One 4: e8340, 2009.
3. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Cervantes F, Sanchez J, Garate L, Barrios M, Castillejo JA, Navarro G, Colomer D, Prosper F, Heiniger A and Torres A: Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene 24: 7213-7223, 2005. (Pubitemid 41679283)
4. Wu SC and Zhang Y: Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol 11: 607-620, 2010.
5. Morgan HD, Santos F, Green K, Dean W and Reik W: Epigenetic reprogramming in mammals. Hum Mol Genet 14: R47-R58, 2005. (Pubitemid 40542620)
6. Dean W, Santos F, Stojkovic M, Zakhartchenko V, Walter J, Wolf E and Reik W: Conservation of methylation reprogramming in mammalian development: aberrant reprogramming in cloned embryos. Proc Natl Acad Sci USA 98: 13734-13738, 2001. (Pubitemid 33115967)
7. Bian Y, Alberio R, Allegrucci C, Campbell KH and Johnson AD: Epigenetic marks in somatic chromatin are remodelled to resemble pluripotent nuclei by amphibian oocyte extracts. Epigenetics 4: 194-202, 2009.
8. Miyamoto K, Tsukiyama T, Yang Y, Li N, Minami N, Yamada M and Imai H: Cell-free extracts from mammalian oocytes partially induce nuclear reprogramming in somatic cells. Biol Reprod 80: 935-943, 2009.
9. Ostrup O, Hyttel P, Klaerke DA and Collas P: Remodeling of ribosomal genes in somatic cells by Xenopus egg extract. Biochem Biophys Res Commun 412: 487-493, 2011.
10. Oliveri RS, Kalisz M, Schjerling CK, Andersen CY, Borup R and Byskov AG: Evaluation in mammalian oocytes of gene transcripts linked to epigenetic reprogramming. Reproduction 134: 549-558, 2007. (Pubitemid 47555048)
11. Morgan HD, Dean W, Coker HA, Reik W and Petersen-Mahrt SK: Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J Biol Chem 279: 52353-52360, 2004. (Pubitemid 39656611)
12. Iqbal K, Jin SG, Pfeifer GP and Szabó PE: Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc Natl Acad Sci USA 108: 3642-3647, 2011.
13. Daskalos A, Nikolaidis G, Xinarianos G, Savvari P, Cassidy A, Zakopoulou R, Kotsinas A, Gorgoulis V, Field JK and Liloglou T: Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer 124: 81-87, 2009.
14. Li QL, Kim HR, Kim WJ, Choi JK, Lee YH, Kim HM, Li LS, Kim H, Chang J, Ito Y, Youl Lee K and Bae SC.: Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun 314: 223-228, 2004. (Pubitemid 38058391)
15. Reinhold WC, Reimers MA, Lorenzi P, Ho J, Shankavaram UT, Ziegler MS, Bussey KJ, Nishizuka S, Ikediobi O, Pommier YG and Weinstein JN: Multifactorial regulation of E-cadherin expression: an integrative study. Mol Cancer Ther 9: 1-16, 2010.
16. Endoh H, Yatabe Y, Shimizu S, Tajima K, Kuwano H, Takahashi T and Mitsudomi T: RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication. Int J Cancer 106: 45-51, 2003. (Pubitemid 36750386)
17. Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I, Reguart N, Rosell R, McCormick F and Jablons DM: Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 64: 4717-4720, 2004. (Pubitemid 38924512)
18. Takezawa K, Okamoto I, Yonesaka K, Hatashita E, Yamada Y, Fukuoka M and Nakagawa K: Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells. Cancer Res 69: 6515-6521, 2009.